Shopping Cart
- Remove All
Your shopping cart is currently empty
CC-115 is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $30 | In Stock | |
| 5 mg | $57 | In Stock | |
| 10 mg | $93 | In Stock | |
| 25 mg | $179 | In Stock | |
| 50 mg | $301 | In Stock | |
| 100 mg | $451 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $64 | In Stock |
| Description | CC-115 is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM). |
| Targets&IC50 | PI3Kα:852 nM, DNA-PK:13 nM, mTOR:21nM |
| In vitro | The IC50 values for CC-115 are >10 μM against a panel of CYP enzymes and >33 μM for the hERG ion channel. When screened in a single point assay at 10 μM against a Cerep receptor and enzyme panel only one target was inhibited >50% (PDE3, IC50 = 0.63 μM). |
| In vivo | CC-115 shows good PK profiles across multiple species with 53%, 76%, and 100% oral bioavailability in mouse, rat, and dog, respectively. CC-115, with favorable physicochemical and pharmacokinetic properties, demonstrates mTOR pathway inhibition and tumor growth inhibition, as well as a good safety profile, suitable for Clinicalal development. |
| Cell Research | Freshly isolated CLL cells are treated with different concentrations of CC-115 for 30 minutes. Subsequently, the cells are exposed to 5-Gy γ-radiation or treated with 10 µg/mL bleomycin (EMD Millipore, Billerica, MA) and incubated for 30 minutes, and cell lysates are made. (Only for Reference) |
| Synonyms | CC 115 |
| Molecular Weight | 336.35 |
| Formula | C16H16N8O |
| Cas No. | 1228013-15-7 |
| Smiles | CCN1C(=O)CNc2ncc(nc12)-c1ccc(nc1C)-c1ncn[nH]1 |
| Relative Density. | 1.56 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 62 mg/mL (184.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.95 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.